aXichem
1.3
SEK
-11.26 %
AXIC A
First North Stockholm
Chemicals
Basic Materials
Be the first to follow this company
-11.26%
-11.56%
-8.13%
+4.84%
-66.59%
-82.28%
-94.15%
-98.45%
-92.3%
www.axichem.com
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.
Revenue
1.81M
EBIT %
-956.91 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
AXIC A
Daily low / high price
1.3 / 1.445
SEK
Market cap
76.85M SEK
Turnover
165.85K SEK
Volume
122K
Financial calendar
Annual report
27.02.2025
Interim report
22.05.2025
General meeting
18.06.2025
Interim report
28.08.2025
Interim report
28.11.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| LMK Bolagen | 15.5 % | 15.5 % |
| Manakin Ltd | 7.2 % | 7.2 % |
| Avanza Pension | 5.3 % | 5.3 % |
| Nordnet Pensionsförsäkring AB | 4.5 % | 4.5 % |
| Aksjesel. Arbejdenes Landsbank | 2.9 % | 2.9 % |
| Myacom Investment AB | 2.8 % | 2.8 % |
| Fenja Capital II | 2.3 % | 2.3 % |
| Sydbank | 2.2 % | 2.2 % |
| Pierre Sahlstrand | 2.1 % | 2.1 % |
| Christian Månsson | 1.9 % | 1.9 % |
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools